Pharming Group N.V. ADS, each representing 10 (PHAR) Live Share Price, Invest From India

Pharming Group N.V. ADS, each representing 10 Stock Performance

as on August 8, 2026 at 2:15 pm IST

Day's Low
Day's High
$10.89
Day's Price Range
$11.08
$10.95
0.55%
Downside
1.19%
Upside
52 Week's Low
52 Week's High
$9.62
52-Week Price Range
$21.34
$10.95
12.15%
Downside
94.89%
Upside

Pharming Group N.V. ADS, each representing 10 share price movements today

Previous Close: $10.85
Open: $11.08
Volume: 202.8K
Day's Low - High: $10.89 - $11.08
52 Week Low - High: $9.62 - $21.34

Pharming Group N.V. ADS, each representing 10 Historical Returns

1 Month Return: -22.72 %
3 Month Return: -16.41 %
1 Year Return: -17.99 %
3 Year Return: -11.57 %
5 Year Return: + 3.01 %

Pharming Group N.V. ADS, each representing 10 Stock Fundamentals & Key Indicators

Check Pharming Group N.V. ADS, each representing 10 market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$755.6M

EPS (TTM)

0.46

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

76.25

Industry PE ratio

-5.3414649681528665

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

2.54%

Return On Equity TTM

3.65%

Pharming Group N.V. ADS, each representing 10 Stock Valuation

Track how Pharming Group N.V. ADS, each representing 10 P/E has moved over time to understand its valuation trends.

Pharming Group N.V. ADS, each representing 10 in the last 5 years

Overview
Trends

Lowest (-186.76x)

March 31, 2025

Industry (-5.34x)

August 9, 2026

Today (76.25x)

August 9, 2026

Highest (115.30x)

March 31, 2022

LowHigh

Today’s Price to Earnings Ratio: 76.25x

Pharming Group N.V. ADS, each representing 10 vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharming Group N.V. ADS, each representing 10 with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Pharming Group N.V. ADS, each representing 10	BUY	$755.6M	3.01%	76.25	2.54%	NA
Revolution Medicines Inc.	BUY	$41.9B	624.31%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.9B	141.53%	27.85	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$79.1B	25.76%	18.83	27.87%	0.48%

Stock Returns calculator for Pharming Group N.V. ADS, each representing 10 Stock including INR - Dollar returns

The Pharming Group N.V. ADS, each representing 10 stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Pharming Group N.V. ADS, each representing 10 investment value today

Current value as on today

₹89,886

Returns

-₹10,114

(-10.11%)

Returns from Pharming Group N.V. ADS, each representing 10 Stock

-₹17,234 (-17.23%)

Dollar Impact

₹7,119 (+7.12%)

Analyst Recommendation on Pharming Group N.V. ADS, each representing 10 Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Pharming Group N.V. ADS, each representing 10. Average target price of $34.35

Pharming Group N.V. ADS, each representing 10 Share Price Target

Get share price movements and forecasts by analysts on Pharming Group N.V. ADS, each representing 10.

What analysts predicted

68.12%UPSIDE

Target Price

$34.35

Current Price

$10.95

Analyzed by

14 Analysts

Target

$34.35

Pharming Group N.V. ADS, each representing 10 target price $34.35, a slight upside of 68.12% compared to current price of $10.95. According to 14 analysts rating.

Indian Investors' Interest in Pharming Group N.V. ADS, each representing 10 Stock

Search interest for Pharming Group N.V. ADS, each representing 10 Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 10, 2026 to August 9, 2026

Change:16% versus previous 30 day period

Pharming Group N.V. ADS, each representing 10 Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	55	74	74	92,700	79	93	97	106	72	90
Gross Profit	47	66	68	80,500	70	84	90	85	65	75
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-12	-1	-1	2,900	-14	4	7	5	-5	1
Net Profit Margin	-22.39%	-1.62%	-1.38%	3.13%	-18.61%	5.04%	7.76%	4.98%	-7.20%	1.82%

Pharming Group N.V. ADS, each representing 10 Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	16	89	135	189	212	225	205	245	307	376
Gross Profit	11	71	129	165	188	201	188	220	271	330
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-18	-73	28	40	37	18	13	-10	-12	2
Net Profit Margin	-110.48%	-81.99%	21.16%	21.41%	17.79%	8.04%	6.65%	-4.30%	-3.98%	0.76%

Global Institutional Holdings in Pharming Group N.V. ADS, each representing 10

Funds	Holdings
Larson Financial Group, LLC	0%
Nalls Sherbakoff Group, LLC	0%
Advisor Group Holdings, Inc.	0%
Coldstream Capital Management Inc	0%
Morgan Stanley - Brokerage Accounts	0.02%

See all

Insights on Pharming Group N.V. ADS, each representing 10

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 72.44M → 90.21M (in $), with an average increase of 19.7% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -5.21M → 1.63M (in $), with an average increase of 418.3% per quarter
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 567.8% return, outperforming this stock by 579.4%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 465.2% return, outperforming this stock by 483.2%
NEGATIVE IMPACT
Price Dip
In the last 1 month, PHAR stock has moved down by -22.7%

About Pharming Group N.V. ADS, each representing 10

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Organisation	Pharming Group N.V. ADS, each representing 10
Headquarters	Darwinweg 24, Leiden, Netherlands, 2333 CR
Industry	Biotechnology
CEO	Mr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.
E-voting on shares	Click here to vote

Key Management of Pharming Group N.V. ADS, each representing 10

Name	Title
Mr. Kenneth Lynard EMBA, M.Sc.	Chief Financial Officer
Ms. Ines Bernal B.A.	Chief People Officer
Dr. Anurag Relan M.D., MPH	Chief Medical Officer
Dr. Alexander Breidenbach M.B.A., Ph.D.	Chief Business Officer
Ms. Leverne Marsh BPHARM	Chief Commercial Officer
Dr. Magnus Hansson	Medical Director
Mr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.	CEO & Executive Director
Ms. Mireille Sanders M.Sc.	Chief Operations Officer
Mr. Michael K. Levitan	VP of Investor Relations & Corporate Communications
Mr. Ruud Van Outersterp L.L.M.	Chief Legal & Compliance Officer and Company Secretary

FAQs

What is Pharming Group N.V. ADS, each representing 10 share price today?

Pharming Group N.V. ADS, each representing 10 share price today is $10.95 as on August 8, 2026 at 8:45 am IST at the close of the market. Pharming Group N.V. ADS, each representing 10 share today touched a day high of $11.08 and a low of $10.89.

What is the 52 week high and 52 week low for Pharming Group N.V. ADS, each representing 10 share?

Pharming Group N.V. ADS, each representing 10 share touched a 52 week high of $21.34 on January 27, 2026 and a 52 week low of $9.62 on July 30, 2026. Pharming Group N.V. ADS, each representing 10 stock price today i.e. August 8, 2026 at 8:45 am IST is closed at $10.95,which is 48.69% down from its 52 week high and 13.83% up from its 52 week low.

What is Pharming Group N.V. ADS, each representing 10's market capitalisation today?

Pharming Group N.V. ADS, each representing 10 market capitalisation is $0.00T as on August 8, 2026 at 8:45 am IST.

How to invest in Pharming Group N.V. ADS, each representing 10 Stock (PHAR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pharming Group N.V. ADS, each representing 10 on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharming Group N.V. ADS, each representing 10 Shares that will get you 0.1370 shares as per Pharming Group N.V. ADS, each representing 10 share price of $10.95 per share as on August 8, 2026 at 8:45 am IST.

What is the minimum amount required to buy Pharming Group N.V. ADS, each representing 10 Stock (PHAR) from India?

Indian investors can start investing in Pharming Group N.V. ADS, each representing 10 (PHAR) shares with as little as ₹95.2 or $1 (as of August 9, 2026 at 9:56 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Pharming Group N.V. ADS, each representing 10 stock (as per the Rupee-Dollar exchange rate as on August 9, 2026 at 9:56 pm IST). Based on Pharming Group N.V. ADS, each representing 10 share’s latest price of $10.95 as on August 8, 2026 at 8:45 am IST, you will get 0.9132 shares of Pharming Group N.V. ADS, each representing 10. Learn more about fractional shares .

What are the returns that Pharming Group N.V. ADS, each representing 10 has given to Indian investors in the last 5 years?

Pharming Group N.V. ADS, each representing 10 stock has given 3.01% share price returns and 27.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?